🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ruth Plummer

Newcastle upon Tyne Hospitals NHS Foundation Trust

ORCID: 0000-0003-0107-1444

Also affiliated with Sir Bobby Robson Foundation, Newcastle University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer”.

Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0986
N/A
2.3DataRank · unranked
94 citations

Debashis Sarker, Vikash Reebye, Sheba Jarvis, Mikael H. Sodergren, Andrew V. Kossenkov +26 more

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study

International Journal of Cancer(2021)10.1002/ijc.33861
N/A
1.9DataRank · unranked
62 citations

Jean‐Yves Blay, Irene García, Johann S. De Bono, Christophe Le Tourneau, Víctor Moreno +25 more

CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002446
N/A
1.0DataRank · unranked
26 citations

Omid Hamid, Elisabeth G.E. de Vries, Patrick A. Ott, Javier García-Corbacho, Valentina Boni +8 more

SARS-CoV-2 vaccination and phase 1 cancer clinical trials

The Lancet Oncology(2021)10.1016/s1470-2045(21)00017-6
N/A
0DataRank · unranked
12 citations

Lillian L. Siu, Emiliano Calvo, Martijn P. Lolkema, Patricia LoRusso, Jean‐Charles Soria +5 more

5MO Comprehensive dose-finding strategy for single-agent RP-3500, a highly selective inhibitor of ataxia telangiectasia and Rad3-related (ATR) kinase

Annals of Oncology(2022)10.1016/j.annonc.2022.01.068
N/A
0DataRank · unranked
3 citations

E. Lee, Ezra Y. Rosen, David R. Spigel, Martin Højgaard, S. Lheureux +15 more

First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2409
N/A
0DataRank · unranked
45 citations

Anthony W. Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking +6 more

Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101435
N/A
0DataRank · unranked
20 citations

Richard Marais, Núria Porta, David González de Castro, Lisa Parsons, Christina Messiou +18 more

A multivariable disease-specific model enhances prognostication beyond current Merkel cell carcinoma staging: An international cohort study of 10,958 patients

Journal of the American Academy of Dermatology(2024)10.1016/j.jaad.2024.10.096
N/A
0DataRank · unranked
2 citations

Sophie Erdmann, Mogdad Alrawi, Ruth Plummer, Sophia Z. Shalhout, V K Sondak +4 more

Poly(ADP-Ribose) Polymerase Inhibitor Development: Promising Strategies to Move Beyond Approved Indications

JCO Precision Oncology(2024)10.1200/po.24.00204
N/A
0DataRank · unranked
2 citations

Ruth Plummer, Timothy A. Yap, Carlos Torrado

Phase Ib Basket Expansion Trial and Alternative-Schedule Dose-Escalation Study of ATR Inhibitor Elimusertib in Advanced Solid Tumors with DNA Damage Response Defects

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1500
N/A
0DataRank · unranked
6 citations

David S.P. Tan, Anastasios Stathis, Geoffrey I. Shapiro, Satoru Iwasa, Markus Joerger +17 more

A hybrid machine learning approach for the personalized prognostication of aggressive skin cancers

npj Digital Medicine(2025)10.1038/s41746-024-01329-9
N/A
0DataRank · unranked
2 citations

Mogdad Alrawi, Ruth Plummer, Nick J. Reynolds, V K Sondak, Isaac Brownell +4 more